SOAS University of London

Serum Institute begins mass production of a vaccine candidate

4 August 2020

The New York Times has reported that the Serum Institute, which is controlled by the Poonawalla family, has begun mass production of the world's most promising coronavirus vaccine. It will produce hundres of millions of doses, even though the vaccine candidate is still in trials. 

The full article details the huge potential benefits and risks that this project entails.